SCHEMBL23918218

SCHEMBL23918218

Clc1ccc2c(c1)Sc1cc(N(c3ccccc3)c3ccc4c(c3)Sc3ccccc3S4)ccc1O2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.37
ACHE P22303 3/20 0.37
NOX1 Q9Y5S8 1/20 0.37
AHR P35869 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
LMNA P02545 2/20 0.34
CYP3A4 P08684 2/20 0.34
SLC22A1 O15245 1/20 0.34
MLNR O43193 1/20 0.34
NR1I2 O75469 1/20 0.34
ABCB11 O95342 1/20 0.34
CHRM2 P08172 1/20 0.34
ADRB1 P08588 1/20 0.34
HTR1A P08908 1/20 0.34
ADRA2A P08913 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
CHRM1 P11229 1/20 0.34
DRD2 P14416 1/20 0.34
DRD1 P21728 1/20 0.34
TBXA2R P21731 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22180416 0.90 AHR (0.36) BCHEACHENOX1AHRTDP1
SCHEMBL23918215 0.90 AHR (0.40) BCHEACHENOX1AHRTDP1
SCHEMBL22180134 0.89 BCHE (0.41) BCHEACHENOX1TDP1LMNA
SCHEMBL23918224 0.89 BCHE (0.41) BCHEACHENOX1TDP1LMNA
SCHEMBL22180408 0.85 AHR (0.35) BCHEACHENOX1AHR
SCHEMBL23918019 0.82 TDP1 (0.30) TDP1LMNACYP3A4SLC22A1MLNR
SCHEMBL22180139 0.81 AHR (0.32) AHR
SCHEMBL16166835 0.81 ALDH1A1 (0.45) BCHEACHENOX1TDP1CYP3A4
SCHEMBL24742169 0.79 KDM4E (0.32)
SCHEMBL22180410 0.79 KDM4E (0.37) AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320258-A1 COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320258-A1 COMPOUND FOR AN ORGANIC ELECTRIC ELEMENT, AN ORGANIC ELECTRIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF PIEZO1, OR10J3, OCIAD1 BCHE 1769/4885ACHE 491/4885NOX1 297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.